Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Plovdiv – page 16

437 clinical trials in Plovdiv, Bulgaria across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Plovdiv at a glance
437
clinical trials
  • Research sites5
Type of trial
Recruitment status
Quick filters

437 trials in Plovdiv

Open in trial search

Immune thrombocytopenia

Not yet recruiting

Study on the Safety and Effectiveness of Budoprutug in Patients with Immune Thrombocytopenia

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BUDOPRUTUG
  • Sponsor:Climb Bio Inc.

Prostate cancer

Not yet recruiting

Study Comparing Rezvilutamide and Bicalutamide with Hormone Therapy for Patients with Advanced Prostate Cancer

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Bicalutamide
  • Sponsor:Jiangsu Hengrui Pharmaceuticals Co. Ltd.

Colitis ulcerative

Not yet recruiting

Study on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Rheumatoid arthritis

Not yet recruiting

Study comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Etanercept
  • Sponsor:Mabxience Research S.L.

Anaemia of chronic disease

Not yet recruiting

Study on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Darbepoetin Alfa
  • Sponsor:Genexine Inc.

Magnetic resonance imaging

Not yet recruiting

Study on How Gadoquatrane Works and Its Safety in Children Undergoing MRI Scans

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:0–17 years
  • Substances:Gadoquatrane
  • Sponsor:Bayer AG

Bacterial infection

Not yet recruiting

Study on Cefiderocol for Treating Gram-negative Bacterial Infections in Hospitalized Infants Under 3 Months

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:0–17 years
  • Substances:Cefiderocol
  • Sponsor:Shionogi B.V.

Renal cell carcinoma

Not yet recruiting

Study comparing XL092 plus nivolumab versus sunitinib for patients with advanced or metastatic non-clear cell kidney cancer

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Exelixis Inc.

Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

Registered drug
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG

Obesity

Not recruiting

Comparing the efficacy and safety of KAI-9531 and semaglutide in people living with obesity who do not have diabetes

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:HRS 9531

Study of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Lansoprazole
  • Sponsor:Cinclus Pharma Holding AB (publ)

Obesity

Not recruiting

Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Metsera Inc.

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Plovdiv

What the registry says about research in the country

01 Infectious Diseases

Ongoing research focuses on influenza virus prevention and hepatitis delta infection treatment. Clinical trials are evaluating new vaccine formulations and therapeutic approaches for viral infections.

  • Influenza Prevention
  • Hepatitis Treatment
  • Bacterial Infections

Studies include testing of adjuvanted vaccines and novel antiviral medications for chronic conditions.

02 Cardiovascular & Metabolic Disorders

Research initiatives targeting hypertriglyceridemia and heart failure prevention. Studies are exploring innovative treatments for metabolic conditions and cardiovascular risk reduction.

  • Heart Failure Prevention
  • Lipid Management
  • Obesity Treatment

Trials evaluate new compounds for managing metabolic disorders and preventing cardiovascular events.

03 Autoimmune Conditions

Comprehensive studies on psoriatic arthritis, Sjögren's disease, and systemic sclerosis. Research focuses on innovative biological therapies and treatment approaches.

  • Arthritis Management
  • Autoimmune Disorders
  • Inflammatory Conditions

Clinical trials are investigating novel therapeutic agents for managing chronic autoimmune conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.